By InvitationNot Applicable

Virtual Reality (VR) Based Relaxation for Nausea and Comfort in Pregnancy

Turkey (Türkiye)90 participantsStarted 2026-03-23

Plain-language summary

This study aims to evaluate the effect of a virtual reality (VR)-based visual relaxation intervention on nausea and vomiting severity, sleep quality, and comfort in pregnant women. Nausea and vomiting are common symptoms during pregnancy and may negatively affect women's quality of life and overall well-being. Non-pharmacological interventions such as VR-based relaxation may provide a safe and effective alternative to improve these symptoms. In this randomized controlled study, pregnant women will be assigned to either an intervention group receiving VR-based relaxation or a control group receiving standard care. The outcomes will be assessed using validated measurement tools for nausea and vomiting severity, sleep quality, and comfort. The findings of this study are expected to contribute to improving maternal comfort and supporting non-invasive care approaches during pregnancy.

Who can participate

Age range

18 Years – 49 Years

Sex

FEMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Women between 6 and 14 weeks of gestation * Pregnancy-specific nausea and vomiting severity measured by PUQE-24 scale scoring 6-10 points * No obstetric complications in the current pregnancy * Aged 18-49 years * Not using antiemetic medications * Not using any pharmacological or non-pharmacological (alternative/complementary) interventions aimed at reducing nausea and vomiting * Willing and able to provide informed consent for participation in the study * Adequate Turkish language proficiency to read and understand study materials Exclusion Criteria: * Diagnosis of hyperemesis gravidarum (HG). * Presence of a diagnosed psychiatric disorder (e.g., depression, anxiety disorder). * Presence of neurological, vestibular, or visual conditions that may prevent the use of a virtual reality headset (e.g., vertigo, epilepsy, migraine, visual impairments). * Classified as a high-risk pregnancy (e.g., multiple pregnancy, history of diabetes, preeclampsia). * Presence of cognitive or communication impairments that would hinder active participation in the study.

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Overall Comfort Scale (GCQ)

Timeframe: Baseline and 24 hours after each session during the study period

Trial details

NCT IDNCT07503080

SponsorFiliz Keskin

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-11

View on ClinicalTrials.gov More Pregnancy trials